Flame spray pyrolyzed carbon-encapsulated Au/Fe3O4 nanoaggregates enabled efficient photothermal therapy and magnetic hyperthermia of esophageal cancer cells
Multifunctional magneto-plasmonic nanoparticles with magnetic hyperthermia and photothermal therapy could kill cancer cells efficiently. Herein, carbon-encapsulated Au/Fe 3 O 4 (Au/Fe 3 O 4 @C) was fabricated using an enclosed flame spray pyrolysis. The nanostructures, including an Fe 3 O 4 core (51...
Gespeichert in:
Veröffentlicht in: | Frontiers in bioengineering and biotechnology 2024-05, Vol.12, p.1400765 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Multifunctional magneto-plasmonic nanoparticles with magnetic hyperthermia and photothermal therapy could kill cancer cells efficiently. Herein, carbon-encapsulated Au/Fe
3
O
4
(Au/Fe
3
O
4
@C) was fabricated using an enclosed flame spray pyrolysis. The nanostructures, including an Fe
3
O
4
core (51.9–55.2 nm) with a decreasing carbon shell thickness and an Au core (4.68–8.75 nm) coated with 2–4 graphite layers, were tailored by tuning the C
2
H
4
content in the reacting gas mixture. Saturation magnetization (33.7–48.2 emu/g) and optical absorption were determined. The carbon shell facilitated the dispersion of Au/Fe
3
O
4
and restrained their laser-induced and magnetic field-induced coalescence and growth. Au/Fe
3
O
4
@C exhibited excellent magnetic resonance imaging capability (91.4 mM
−1
s
−1
) and photothermal performance (65.4°C for 0.8 mg/mL Au/Fe
3
O
4
@C at a power density of 1.0 W/cm
2
after 300 s near-IR laser irradiation (808 nm)). Moreover, the combined application of photothermal and magnetic-heating properties reduced the required intensity of both laser and magnetic field compared to the intensity of separate situations. Our work provides a unique, intriguing approach to preparing multicomponent core/shell nanoaggregates that are promising candidates for esophageal cancer cell therapy. |
---|---|
ISSN: | 2296-4185 2296-4185 |
DOI: | 10.3389/fbioe.2024.1400765 |